W0265-104: A SINGLE-CENTER, EVALUATOR-BLINDED, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 1 CLINICAL TRIAL EVALUATING THE PHOTOALLERGIC POTENTIAL OF TOPICALLY APPLIED CLINDAMYCIN PHOSPHATE 1.0% AND TRETINOIN 0.025% (CT GEL) IN HEALTHY VOLUNTEERS: